Cargando…

Identifying Predictive Factors of Recurrence after Radical Resection in Gastric Cancer by RNA Immune-oncology Panel

Aiming to identify novel immunotargets for gastric cancer (GC), we retrospectively analyzed the formalin-fixed paraffin embedded (FFPE) samples of gastric cancer tissues from postoperative patients who relapsed or metastasized within (early recurrence, n=25) or after two years (late recurrence, n=23...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yuehong, Yu, Shan, Zhu, Mengxuan, Cheng, Xi, Yu, Yiyi, Tang, Zhaoqing, Wang, Xuefei, Hou, Jun, Hou, Yingyong, Ren, Dandan, Mao, Beibei, Khalid, Rashid, Liu, Tianshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959033/ https://www.ncbi.nlm.nih.gov/pubmed/31942187 http://dx.doi.org/10.7150/jca.38536

Ejemplares similares

NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer
por: Cui, Yuehong, et al.
Publicado: (2021)

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial
por: Tang, Zhaoqing, et al.
Publicado: (2022)

Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
por: Cui, Yuehong, et al.
Publicado: (2022)

Five Cases Report of Solid Tumor Synchronously with Hematologic Malignancy
por: Cui, Yuehong, et al.
Publicado: (2012)

ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
por: Xu, Xiaojing, et al.
Publicado: (2019)

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA)
por: Cui, Yuehong, et al.
Publicado: (2023)

Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer
por: Liang, Li, et al.
Publicado: (2021)

Effectiveness of oncology nurse navigator on the incidence of postoperative pulmonary complications in gastric cancer patients undergoing radical gastrectomy
por: Yan, Yamin, et al.
Publicado: (2023)

The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
por: Tang, Zhaoqing, et al.
Publicado: (2022)

Correction: Effectiveness of oncology nurse navigator on the incidence of postoperative pulmonary complications in gastric cancer patients undergoing radical gastrectomy
por: Yan, Yamin, et al.
Publicado: (2023)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Risk Factors for Recurrence of Radically Resected Mucinous Colorectal Adenocarcinoma
por: Huang, Qing, et al.
Publicado: (2021)

Risk Assessment and Preventive Treatment for Peritoneal Recurrence Following Radical Resection for Gastric Cancer
por: Xiang, Lin, et al.
Publicado: (2022)

Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection
por: Feng, Jiliang, et al.
Publicado: (2017)

Mining the role of angiopoietin‐like protein family in gastric cancer and seeking potential therapeutic targets by integrative bioinformatics analysis
por: Tang, Cheng, et al.
Publicado: (2020)

Is Late Recurrence after Radical Resection for Ampullary Carcinoma A Problem?
por: Strasberg, Steven M.
Publicado: (1995)

Robot - assisted laparoscopic local recurrence resection after radical prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2019)

Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study
por: Li, Qi, et al.
Publicado: (2022)

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Radically resected node-negative squamous cell carcinoma of thoracic esophagus: recurrence pattern and indication for adjuvant therapy
por: Fang, W, et al.
Publicado: (2013)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2020)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer
por: Wang, Fei, et al.
Publicado: (2022)

Adenocarcinoma of the ampulla of Vater: predictors of survival and recurrence after curative radical resection
por: Kim, Kang Jae, et al.
Publicado: (2011)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

Clinicopathological Characteristics of Primary Appendiceal Mucinous Neoplasm and Recurrence After Radical Resection
por: Wang, Zaibiao, et al.
Publicado: (2022)

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma
por: Zhu, Qiaoliang, et al.
Publicado: (2020)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen
por: Tang, Cheng, et al.
Publicado: (2018)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type
por: Lee, Boram, et al.
Publicado: (2021)

Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative, oncologic and functional outcomes
por: Hung, Chi-Feng, et al.
Publicado: (2014)

Different long-term oncologic outcomes after radical surgical resection for neuroendocrine carcinoma and adenocarcinoma of the stomach
por: Xie, Jian-Wei, et al.
Publicado: (2017)

Ca(v)2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization
por: Xue, Ying, et al.
Publicado: (2022)

Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study
por: Zhang, Lingyun, et al.
Publicado: (2022)

Definitive chemoradiotherapy and salvage chemotherapy for patients with isolated locoregional recurrence after radical resection of primary pancreatic cancer
por: Shi, Wei, et al.
Publicado: (2019)

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
por: Sanfiorenzo, Céline, et al.
Publicado: (2013)

Lateral approach is a more aesthetical option for radical resection of BSCC: assessment of its surgical, oncological, functional, and aesthetic outcomes
por: Wan, Wen-Dong, et al.
Publicado: (2022)

Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Complete endoscopic radical resection of thyroid cancer via an oral vestibule approach
por: Bian, Cong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7rn6nfg6bhtug8sqh18h2545t8